Join us for the first part of our two-part webinar series on innovation in clinical trials, where we will explore how artificial intelligence (AI) is transforming efficiency and quality. Our expert speakers will delve into the use of AI-powered solutions, focusing on the shift towards agentic and generative AI applications in clinical trials. They will provide several examples of AI in clinical development, including:
- Enhancing clinical development strategy planning with AI-powered technology, which enables the creation of various scenarios to optimize country and site mix for enrollment strategies. This technology also offers options for sponsors to make informed decisions based on study duration and cost, and improves site selection by identifying the best sites for specific indications.
- Improving clinical monitoring support with GenAI, which uses natural language processing to help researchers administer clinical processes more effectively and quickly answer questions to ensure compliance with protocol guidelines.
- Augmenting monitoring support with an agentic AI platform that performs ad-hoc data summaries to address monitoring and operational questions, and provides AI explanations and data source references to users’ queries.
Register for this webinar today to discover how artificial intelligence is revolutionizing the efficiency and quality of clinical trials.
Speakers
Jonas Renstroem, Director, Digital Strategy & Innovation, IQVIA
Jonas Renstroem is a Director at IQVIA based in Sweden. He has been instrumental in the development of Centralized Monitoring and Site Support capabilities that drive risk-based monitoring and the future of clinical operations. His expertise spans clinical trial process design, remote monitoring, clinical study leadership, decentralized trials, AI/ML, GenAI and risk-based monitoring.
Jonas has a PhD in experimental haematology from TUM, Munich, Germany alongside a MSc and an MEd, both from Uppsala University, Uppsala, Sweden.
Message Presenter
Laurence Lin, Associate Director, AI Scientist, IQVIA
Laurence Lin is an AI Scientist, Clinical Operations where he leads various business solutions using AIML, Gen AI and Agentic AI to drive insights, predictions and tools for business users and clients. He is a Mathematics major with decades of experience in Math and Statistics modeling and AIML modeling. He has also led or participated in several US patents in technology, analytics and digital transformation.
Message PresenterWho Should Attend?
This webinar will appeal to senior professionals (Director level and above) from pharma and biotech companies working within:
- Clinical Operations
- Digital Innovation Leads
- Procurement
- Therapeutic Leads
- Centralizing Monitoring
What You Will Learn
Attendees will learn about:
- How generative AI and agentic AI can improve quality and efficiency in clinical research
- How to safeguard generative AI and agentic AI outputs for business use in terms of privacy and reliability
- How to enable clinical staff to be champions enabled by AI-powered solutions
Xtalks Partner
IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account